整合3D-QSAR,分子对接和机器学习技术,以合理设计基于尼古丁胺胺的SIRT2抑制剂
Aleksandra Ilic1, Nemanja Djokovic1, Teodora Djikic1
1Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Belgrade, Vojvode Stepe 450, Belgrade 11000, Serbia.
Computational biology and chemistry
|October 15, 2024
概括
研究人员开发了计算模型来设计用于癌症和神经退行性疾病的新型选择性Sirtuin-2 (SIRT2) 抑制剂. 这些模型预测药物的有效性和选择性,有助于识别有前途的治疗候选者.
科学领域:
- 药用化学 医学化学
- 计算机化药物设计技术
- 药理学 药理学是指药理学的学科.
背景情况:
- 选择性Sirtuin-2 (SIRT2) 抑制剂对癌症和神经退行性疾病具有治疗潜力.
- 尼古丁胺衍生物是强效和选择性的SIRT2抑制剂.
- 需要可靠的计算模型来指导新型SIRT2抑制剂的设计.
研究的目的:
- 开发一种基于尼古丁胺胺的SIRT2抑制剂的3D定量结构-活性关系 (3D-QSAR) 模型.
- 为设计新型抑制剂生成GRIND衍生药模型.
- 开发分类模型来预测SIRT1/2和SIRT2/3的选择性.
主要方法:
- 使用 86 种基于尼古丁胺胺的 SIRT2 抑制剂的数据集开发 3D-QSAR 模型.
- 来自GRIND的药模型的生成.
- 基于分子对接的选择性预测的天真贝叶斯和k-最近邻居分类模型的开发.
主要成果:
- 建立了一个可靠的3D-QSAR模型来预测SIRT2抑制.
- 新型SIRT2抑制剂的设计是基于开发的药模型.
- 选择性模型表明SIRT1/2和SIRT2/3抑制的预测能力.
结论:
- 3D-QSAR,选择性模型和ADMET预测的整合确定了有前途的选择性SIRT2抑制剂.
- 开发的计算方法有助于发现SIRT2相关疾病的新疗法.
- 这项研究为针对SIRT2.2的合理药物设计提供了一个框架.
更多相关视频
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
505
10:21Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
Published on: February 23, 2024
2.4K
相关概念视频
Structure-Activity Relationships and Drug Design
668
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
668
Ligand Binding Sites
12.8K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.8K
